Meta Pharmaceuticals Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$5.75M
- Investors
-
8
Meta Pharmaceuticals General Information
Description
Manufacturer of immunometabolism-based therapeutics designed to treat autoimmune and metabolic disorders through targeted modulation of immune cell metabolism. The company offers proprietary immunometabolism research capabilities, novel metabolic enzyme drug targets, and an AI-assisted drug discovery platform, enabling biopharmaceutical researchers and patients with chronic immune-related conditions to access innovative therapeutic approaches with the potential for improved efficacy and safety.
Contact Information
Website
www.metabiopharma.comCorporate Office
- 4th Floor, Block C, Phase II
- Futian International Biomedical Park
- Shenzhen, 518000
- China
Corporate Office
- 4th Floor, Block C, Phase II
- Futian International Biomedical Park
- Shenzhen, 518000
- China
Meta Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A1) | 01-Dec-2024 | $5.75M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 13-Jun-2022 | Completed | Generating Revenue |
Meta Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Meta Pharmaceuticals Patents
Meta Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4695266-A1 | Substituted alkanoic-diacids compound and composition and use thereof | Pending | 14-Apr-2023 | ||
| EP-4695242-A1 | Novel substituted pyrrole compounds, compositions comprising the substituted pyrrole compound, and methods of use thereof | Pending | 09-Apr-2023 |
Meta Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Meta Pharmaceuticals Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bopu Asset | Hedge Fund | Minority | ||
| Decent Capital | Family Office | Minority | ||
| Forcefield Venture | Venture Capital | Minority | ||
| IMO Ventures | Venture Capital | Minority | ||
| Qian hai Fangyuan Capital | Venture Capital | Minority |
Meta Pharmaceuticals FAQs
-
When was Meta Pharmaceuticals founded?
Meta Pharmaceuticals was founded in 2021.
-
Where is Meta Pharmaceuticals headquartered?
Meta Pharmaceuticals is headquartered in Shenzhen, China.
-
What is the size of Meta Pharmaceuticals?
Meta Pharmaceuticals has 9 total employees.
-
What industry is Meta Pharmaceuticals in?
Meta Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Meta Pharmaceuticals a private or public company?
Meta Pharmaceuticals is a Private company.
-
What is Meta Pharmaceuticals’s current revenue?
The current revenue for Meta Pharmaceuticals is .
-
How much funding has Meta Pharmaceuticals raised over time?
Meta Pharmaceuticals has raised $20.9M.
-
Who are Meta Pharmaceuticals’s investors?
Bopu Asset, Decent Capital, Forcefield Venture, IMO Ventures, and Qian hai Fangyuan Capital are 5 of 8 investors who have invested in Meta Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
